After Merck announced the launch of a beta version of M-Trust™, a secure cyber-physical trust platform, created to help solve the growing issues of product safety, traceability and counterfeiting, EPM asked some follow-ups questions to learn more.
Dr. James McCracken, senior commercial product manager at Beckman Coulter Life Sciences, discusses how cell sorting is a popular and growing use of flow cytometry – and one that many researchers rely on specialists to perform.
Anne Dhulesia, partner, Sean Dyson, partner, and Guy Stephens, manager, L.E.K. Consulting, discuss how oncology is the single largest therapeutic area for pharmaceutical sales worldwide.
It’s that time of year again when we take stock of the advances the biopharma industry has made and look ahead to the evolving client requirements that will shape 2025 and beyond. Subodh Deshmukh, CEO of Aragen Bioscience discusses.
Pharmapack Europe & CPHI have outlined key trends for pharma in 2025, highlighting the return of funding liquidity—via increased VC investments and PE capital for M&A.
With the medtech sector booming, established and growing businesses need help in optimising their processes and their innovative products to achieve growth and build on their competitive advantage.
Greiner Packaging UK & Ireland asks: "How do you know the CO2e impact of your plastic packaging?", and goes on to question how you can properly know what percentage of post-consumer waste a pack contains.
Michael Burkhard and Amr Eltablawi, Hexagon Asset Lifecycle Intelligence, delve into the top trends shaping pharmaceutical and life sciences operations in 2025.
Owkin has launched its latest report, State of the Nation: Opportunities and Challenges for Digital Pathology and AI Solutions, exploring the evolving landscape of digital pathology and AI in healthcare in the UK.
Investors worldwide are scouring for their next big win after the door to the extremely lucrative obesity market was opened by pharmaceutical giants Novo Nordisk and Eli Lilly. Now benefiting on the Swedish stock exchange is a smaller biotech company
